Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy
- 11 September 2018
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 27 (5) , 1919-1925
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperatureThe Breast, 2016
- Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopeciaSupportive Care in Cancer, 2016
- Factors Influencing the Effectiveness of Scalp Cooling in the Prevention of Chemotherapy-Induced AlopeciaThe Oncologist, 2013
- Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling RegistryActa Oncologica, 2012
- Impact of alopecia and scalp cooling on the well‐being of breast cancer patientsPsycho-Oncology, 2010
- Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerationsSupportive Care in Cancer, 2008
- Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature reviewPsycho-Oncology, 2007
- Prevention of chemotherapy-induced hair loss by scalp coolingAnnals of Oncology, 2005
- Cancer and stigma: experience of patients with chemotherapy-induced alopeciaPatient Education and Counseling, 2004
- Pharmacokinetics of adriamycin in patients with breast cancer: Correlation between pharmacokinetic parameters and clinical short-term responseEuropean Journal of Cancer and Clinical Oncology, 1982